×
Pour une meilleure utilisation, nous vous conseillons d’activer Javascript dans votre navigateur.
DLL4 anticorps
DLL4
Reactivité: Humain
FACS
Hôte: Souris
Monoclonal
MHD4-46
unconjugated
N° du produit ABIN2749211
Détail du produit anti-DLL4 anticorps
(cache)
Antigène
Voir toutes DLL4 Anticorps
DLL4
(delta-Like 4 (DLL4))
Reactivité
Toutes les réactivités sur DLL4 Anticorps
Humain
Hôte
Toutes les hôtes sur DLL4 Anticorps
Souris
Clonalité
Toutes les clonalités sur DLL4 Anticorps
Monoclonal
Conjugué
Tous les conjugués à travers DLL4 Anticorps
Cet anticorp DLL4 est non-conjugé
Application
Tous les applications à travers DLL4 Anticorps.
Flow Cytometry (FACS)
Specificité
The mouse monoclonal antibody MHD4-46 recognizes the extracellular domain of DLL4 (Delta-like ligand 4), a type I transmembrane protein which plays an important role in vascular development.
Réactivité croisée (Details)
Human
Purification
Purified by protein-A affinity chromatography.
Pureté
> 95 % (by SDS-PAGE)
Immunogène
recombinant soluble human DLL4
Clone
MHD4-46
Isotype
IgG1 kappa
Top Product
Discover our top product DLL4 Anticorps primaire
Alternatives
(show)
Information d'application
(cache)
Indications d'application
Flow cytometry: Recommended dilution: 1-4 μg/mL
Restrictions
For Research Use only
Stockage
(cache)
Concentration
1 mg/mL
Buffer
Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
4 °C
Stockage commentaire
Store at 2-8°C. Do not freeze.
Références pour anticorps anti-DLL4 (ABIN2749211)
(cache)
Sekine, Koyanagi, Koyama, Hozumi, Chiba, Yagita : "Differential regulation of osteoclastogenesis by Notch2/Delta-like 1 and Notch1/Jagged1 axes. " dans: Arthritis research & therapy , Vol. 14 , Issue 2 , pp. R45 , (2012 ) (PubMed ).
Oishi, Sunamura, Egawa, Motoi, Unno, Furukawa, Habib, Yagita : "Blockade of delta-like ligand 4 signaling inhibits both growth and angiogenesis of pancreatic cancer. " dans: Pancreas , Vol. 39 , Issue 6 , pp. 897-903 , (2010 ) (PubMed ).
Yamanda, Ebihara, Asada, Okazaki, Niu, Ebihara, Koyanagi, Yamaguchi, Yagita, Arai : "Role of ephrinB2 in nonproductive angiogenesis induced by Delta-like 4 blockade. " dans: Blood , Vol. 113 , Issue 15 , pp. 3631-9 , (2009 ) (PubMed ).
Détails sur DLL4
(cache)
Antigène
DLL4
(delta-Like 4 (DLL4))
Autre désignation
DLL4 (DLL4 Produits )
Synonymes
anticorps hdelta2, anticorps Delta4, anticorps si:ch211-244p18.5, anticorps zgc:136596, anticorps delta like canonical Notch ligand 4, anticorps delta-like 4 (Drosophila), anticorps DLL4, anticorps Dll4, anticorps dll4
Sujet
Delta like canonical Notch ligand 4,DLL4 (Delta-like 4) is one of five ligands of Notch receptors. It interacts with Notch1 and Notch4. DLL4 is up-regulated at sites of physiologic and pathologic angiogenesis, whereas its expression is low in most adult normal tissues. It is also highly expressed in human clear-cell renal carcinomas, bladder cancers, and breast cancers. Blocking the DLL4-Notch interaction seems to be a promissing therapeutic approach.,Delta like ligand 4, AOS6, canonical Notch ligand 4
ID gène
54567
UniProt
Q9NR61
Pathways
Signalisation Notch
Vus récemment
(cache)